Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue increased on strong sales of products for industrial equipment, medical and healthcare applications. The increase in revenue was insufficient to fully absorb higher raw material prices and labor costs, resulting in an operating loss.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥5,784,902 thousand (YoY +1.5%) |
| Operating profit | ¥-70,766 thousand |
| Ordinary income | ¥-54,502 thousand |
| Profit attributable to owners of the parent | ¥-12,171 thousand |
| Net income per share | -¥1.48 |
| Equity ratio | End of the current fiscal period 42.8% / End of previous period 41.7% |
| Total assets | ¥10,709,660 thousand |
| Net assets | ¥4,586,504 thousand |
| Cash flows from operating activities | ¥315,198 thousand |
| Cash flows from investing activities | ¥-128,203 thousand |
| Cash flows from financing activities | ¥-175,760 thousand |
| Cash and cash equivalents at end of period | ¥2,182,830 thousand |
| Full-year earnings forecast | Net Sales ¥5,943 million / Operating profit ¥84 million / Ordinary income ¥23 million / Net income ¥2 million |
| Depreciation and amortization | ¥616,357 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥225,862 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥4,759 thousand, Impairment Loss on Investment Securities ¥3,765 thousand, Loss on reversal of foreign currency translation adjustment ¥129,075 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Material subsequent events | Not applicable. |
| Factors Behind Changes in Business Performance | Revenue increased on strong sales of products for industrial equipment, medical and healthcare applications. The increase in revenue was insufficient to fully absorb higher raw material prices and labor costs, resulting in an operating loss. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Strong sales of products for industrial equipment, medical and healthcare applications contributed to higher revenue. However, the increase in revenue was insufficient to fully absorb higher raw material prices and labor costs. The Company expects to improve profitability in the next fiscal year through the effect of higher revenue, improved production efficiency and ongoing cost reductions.